1
Melanoma Perception and Health Literacy in People of Color
Condition(s):MelanomaLast Updated:November 30, 2016Completed
Melanoma: 2729 Clinical Trials, Page 1 of 28
Hide Studies Not Open or Pending
2
Skin Care Behaviors Among Melanoma Survivors and Their Families
Condition(s):MelanomaLast Updated:December 17, 2018Completed
3
Prospective Melanoma Database
Condition(s):MelanomaLast Updated:August 25, 2016Recruiting
4
Tracing Dissemination of Melanoma Cells in Healthy Tissues
Condition(s):MelanomaLast Updated:March 1, 2018Recruiting
5
Nivolumab/Ipilimumab Plus Cabozantinib in Patients With Unresectable Advanced Melanoma
Condition(s):MelanomaLast Updated:September 16, 2019Not yet recruiting
6
18F‐Labeled Picolinamide PET Imaging of Melanoma Diagnosis
Condition(s):MelanomaLast Updated:January 24, 2017Unknown status
7
Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma
Condition(s):MelanomaLast Updated:September 11, 2019Not yet recruiting
8
Safety Study of a Melanoma Vaccine (GVAX) With or Without Cyclophosphamide in Patients With Surgically Resected Melanoma
Condition(s):MelanomaLast Updated:May 23, 2016Completed
9
Molecular Characterization of Advanced Stage Melanoma by Blood Sampling
Condition(s):Metastatic MelanomaLast Updated:February 22, 2019Active, not recruiting
10
Clinical and Histological Features of Head and Neck Melanoma
Condition(s):MelanomaLast Updated:August 25, 2016Completed
11
Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma
Condition(s):MelanomaLast Updated:March 12, 2019Active, not recruiting
12
Characterization of the Melanoma-Specific Immune Response
Condition(s):MelanomaLast Updated:June 10, 2019Recruiting
13
Quality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)
Condition(s):Melanoma (Skin) Stage IV; RemissionLast Updated:July 18, 2018Completed
14
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Condition(s):Cutaneous Melanoma, Stage IILast Updated:March 1, 2019Not yet recruiting
15
MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma
Condition(s):Cutaneous Melanoma by AJCC V7 StageLast Updated:August 30, 2018Active, not recruiting
16
Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma
Condition(s):MelanomaLast Updated:June 25, 2014Completed
17
Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma
Condition(s):MelanomaLast Updated:October 22, 2019Recruiting
18
Study of Oral Azacitidine (CC-486) in Combination With Pembrolizumab (MK-3475) in Patients With Metastatic Melanoma
Condition(s):Melanoma and Other Malignant Neoplasms of Skin; Metastatic MelanomaLast Updated:September 4, 2019Recruiting
19
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) Melanoma
Condition(s):Metastatic NRAS MelanomaLast Updated:June 6, 2019Not yet recruiting
20
Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist
Condition(s):Patients at Risk for MelanomaLast Updated:April 26, 2019Completed
21
Evaluation of the Immunogenicity of Vaccination With Multiple Synthetic Melanoma Peptides With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With Advanced Melanoma
Condition(s):MelanomaLast Updated:April 30, 2018Completed
22
Melanoma Image Analysis Algorithm (MIAA) Validation Study
Condition(s):Malignant MelanomaLast Updated:January 24, 2019Completed
23
MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients
Condition(s):MelanomaLast Updated:November 9, 2016Not yet recruiting
24
Melanoma Accuracy Study; Phase 2
Condition(s):MelanomaLast Updated:March 7, 2018Not yet recruiting
25
Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
Condition(s):MelanomaLast Updated:August 7, 2019Enrolling by invitation
26
Melanoma Risk-Reduction Among Patients and Family Members
Condition(s):MelanomaLast Updated:May 22, 2019Active, not recruiting
27
Evaluation of a Simulation Training Tool to Identify Lesions Requiring Further Screening for Melanoma
Condition(s):Skin Simulation Model; Mastery Learning Model to Simulation Training for Visual Screening for Melanoma and Skin BiopsyLast Updated:September 24, 2014Completed
28
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
Condition(s):Melanoma Stage Iv; Melanoma Stage Iii; Advanced CancerLast Updated:May 27, 2019Recruiting
29
Characterisation of T Lymphocytes, NK Cells and Macrophages in Melanoma Patients
Condition(s):MelanomaLast Updated:August 25, 2014Completed
30
HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma
Condition(s):MelanomaLast Updated:February 9, 2018Recruiting
31
French Clinical Datbase of Melanoma Patients (RIC-Mel)
Condition(s):Melanoma (Skin)Last Updated:November 20, 2018Recruiting
32
Trial for the Evaluation of the Effect of Systemic Low-dose Interleukin-2 (IL-2) on the Immunogenicity of a Vaccine Comprising Synthetic Melanoma Peptides Administered With Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)-In-Adjuvant, in Patients With High Risk Melanoma
Condition(s):MelanomaLast Updated:October 20, 2010Completed
33
Adoptive Transfer of Specific Melanoma Antigens CD8+ T Cells in Metastatic Melanoma Patients: a Phase I/II Study
Condition(s):Metastatic MelanomaLast Updated:June 24, 2019Recruiting
34
The Effectiveness of Nivolumab Monotherapy as First-Line Therapy in Adults With Advanced Melanoma in Germany
Condition(s):MelanomaLast Updated:April 5, 2018Withdrawn
35
Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma
Condition(s):MelanomaLast Updated:April 25, 2018Completed
36
Immunotherapy Study for Patients With Stage IV Melanoma
Condition(s):Stage IV Melanoma; Metastatic MelanomaLast Updated:May 17, 2019Active, not recruiting
37
Trial of Surgical Excision Margins in Thick Primary Melanoma – 2
Condition(s):Melanoma; Surgery; Treatment OutcomeLast Updated:August 16, 2018Completed
38
Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF)
Condition(s):MelanomaLast Updated:July 16, 2019Active, not recruiting
39
Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
Condition(s):Advanced Melanoma; Untreated PatientsLast Updated:December 6, 2009Unknown status
40
Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases
Condition(s):Melanoma; In-Transit Metastasis of Cutaneous MelanomaLast Updated:September 11, 2019Not yet recruiting
41
A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma
Condition(s):High Risk MelanomaLast Updated:July 3, 2019Completed
42
Comparison of Video-Based Versus Written Patient Education on Melanoma
Condition(s):Melanoma; Malignant MelanomaLast Updated:April 20, 2015Completed
43
Dendritic Cells (DC) Vaccine for Metastatic Melanoma
Condition(s):Metastatic MelanomaLast Updated:July 16, 2017Terminated
44
Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma
Condition(s):Melanoma CancerLast Updated:August 22, 2016Unknown status
45
Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma
Condition(s):Malignant MelanomaLast Updated:February 4, 2019Recruiting
46
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma
Condition(s):MelanomaLast Updated:June 25, 2019Active, not recruiting
47
Radiotherapy & Combi in Metastatic Melanoma
Condition(s):Metastatic MelanomaLast Updated:July 17, 2019Recruiting
48
Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
Condition(s):MelanomaLast Updated:April 21, 2016Completed
49
MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma
Condition(s):Melanoma; MetastasesLast Updated:June 29, 2011Completed
50
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
Condition(s):MelanomaLast Updated:February 5, 2018Completed
51
Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Condition(s):MelanomaLast Updated:June 27, 2019Active, not recruiting
52
Vaccination Plus Ontak in Patients With Metastatic Melanoma
Condition(s):MelanomaLast Updated:September 8, 2017Unknown status
53
Utility of Novel BRAF Test for Melanoma
Condition(s):MelanomaLast Updated:May 20, 2019Active, not recruiting
54
Achieving Self-directed Integrated Cancer Aftercare (ASICA) in Melanoma
Condition(s):MelanomaLast Updated:July 11, 2019Active, not recruiting
55
Pilot Study of Infrared Imaging of Cutaneous Melanoma
Condition(s):MelanomaLast Updated:December 19, 2014Completed
56
Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)
Condition(s):MelanomaLast Updated:August 6, 2019Recruiting
57
A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
Condition(s):MelanomaLast Updated:December 2, 2015Unknown status
58
cKIT, BRAF/NRAS Mutations in Advanced Melanoma : Clinical Outcome in Response to Tyrosine-kinase Inhibitors – KitMel Project
Condition(s):MelanomaLast Updated:February 21, 2014Completed
59
Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
Condition(s):MelanomaLast Updated:November 14, 2016Withdrawn
60
Sun Exposure and Melanoma in Agricultural Workers
Condition(s):MelanomaLast Updated:January 24, 2019Completed
61
PD-L1 PET Imaging in Melanoma Patients
Condition(s):MelanomaLast Updated:April 18, 2019Recruiting
62
Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Condition(s):Uveal Melanoma; Hepatic MetastasesLast Updated:September 16, 2019Recruiting
63
Melanoma Molecular Profiling Analysis
Condition(s):MelanomaLast Updated:June 10, 2019Recruiting
64
APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma
Condition(s):MelanomaLast Updated:October 3, 2019Recruiting
65
In Vivo Persistence of Adoptively-Transferred TIL Cultured With Akti in People With Metastatic Melanoma
Condition(s):Metastatic MelanomaLast Updated:July 26, 2017Withdrawn
66
Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma
Condition(s):MelanomaLast Updated:July 23, 2013Completed
67
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
Condition(s):MelanomaLast Updated:August 5, 2019Completed
68
Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma
Condition(s):Completely Resectable Stage IIIB, IIIC, or IVM1a MelanomaLast Updated:October 23, 2019Active, not recruiting
69
A Randomized Controlled Phase II Trial With Intradermal IMO-2125 in Pathological Tumor Stage (p) T3-4 cN0M0 Melanoma
Condition(s):Malignant MelanomaLast Updated:October 24, 2019Not yet recruiting
70
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Condition(s):High Risk HLA-A2+ Melanoma; Metastatic DiseaseLast Updated:May 23, 2013Unknown status
71
Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma
Condition(s):Metastatic MelanomaLast Updated:May 22, 2015Terminated
72
Analysis of Skin Lesions for Melanoma Presence by Volatile Spectroscopy Techniques
Condition(s):MelanomaLast Updated:July 23, 2019Completed
73
Co-stimulatory Markers and Vitamin D Status in Anti-PD1 Treated Melanoma Patients
Condition(s):Malignant MelanomaLast Updated:June 22, 2017Enrolling by invitation
74
Combination Therapy of Topical Imiquimod Plus Multipeptide Vaccination for Cutaneous Metastases of Melanoma
Condition(s):MelanomaLast Updated:December 15, 2016Completed
75
Temodar and Sutent as Therapy for Melanoma
Condition(s):Metastatic Malignant MelanomaLast Updated:February 3, 2009Terminated
76
Biochemotherapy and Bevacizumab Followed by Consolidation Therapy With Ipilimumab for Metastatic Melanoma
Condition(s):Metastatic MelanomaLast Updated:August 28, 2013Completed
77
Whole-body DW-MRI and cfDNA Analysis for the Surveillance of Melanoma Patients at High Risk for Recurrence.
Condition(s):MelanomaLast Updated:January 22, 2019Recruiting
78
Interest of Tumor Replicates in Avian Embryo to Model Therapeutic Effects of BRAFi/MEKi in BRAF Mutated Melanoma
Condition(s):MelanomaLast Updated:July 29, 2019Not yet recruiting
79
An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma
Condition(s):MelanomaLast Updated:October 2, 2019Recruiting
80
Anti‐PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases
Condition(s):Melanoma; Brain MetastasesLast Updated:April 10, 2019Active, not recruiting
81
Molecular Characterization of Primary Mucosal Melanoma
Condition(s):Mucosal MelanomaLast Updated:October 23, 2017Unknown status
82
PVSRIPO in Combination With Nivolumab in Melanoma
Condition(s):MelanomaLast Updated:October 11, 2019Not yet recruiting
83
Early Diagnosis of Melanoma Using Expression Profiling and Non-Invasive Sampling of Skin Cells
Condition(s):MelanomaLast Updated:April 20, 2015Terminated
84
IL-2 “SELECT” Tissue Collection Protocol in Patients With Advanced Melanoma
Condition(s):Malignant MelanomaLast Updated:February 9, 2019Active, not recruiting
85
A Real-World Study of Ipilimumab Treatment After Nivolumab Treatment in Melanoma in Japan
Condition(s):MelanomaLast Updated:October 21, 2019Completed
86
A Research Study of Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.
Condition(s):Melanoma (Skin)Last Updated:August 13, 2018Enrolling by invitation
87
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
Condition(s):MelanomaLast Updated:October 17, 2019Recruiting
88
Peripheral Blood and/or Bone Marrow, Including Detection of Occult Metastases, in Patients With Melanoma
Condition(s):MelanomaLast Updated:October 1, 2009Completed
89
Definition of an Immune Signature Predictive of Anti-PD1 (Programmed Death-1) Antibody in the Treatment of Advanced Melanoma
Condition(s):Malignant MelanomaLast Updated:October 24, 2016Not yet recruiting
90
Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients
Condition(s):Malignant MelanomaLast Updated:September 17, 2018Recruiting
91
Everolimus in Selected Patients With Metastatic Melanoma: Efficacy and Safety Study
Condition(s):Melanoma; TOR Serine-Threonine Kinases; Neoplasm MetastasisLast Updated:April 30, 2015Unknown status
92
In Vivo Real-time Detection of Circulating Melanoma Cells
Condition(s):MelanomaLast Updated:March 28, 2019Recruiting
93
M-Vax + Low Dose Interleukin-2 Versus Placebo Vaccine in Metastatic Melanoma in Patients With Stage IV Melanoma
Condition(s):MelanomaLast Updated:December 2, 2015Not yet recruiting
94
LY3022855 With BRAF/MEK Inhibition in Patients With Melanoma
Condition(s):MelanomaLast Updated:August 6, 2019Active, not recruiting
95
Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma
Condition(s):MelanomaLast Updated:October 3, 2019Recruiting
96
Vorinostat in Patients With Class 2 High Risk Uveal Melanoma
Condition(s):Uveal MelanomaLast Updated:October 23, 2019Suspended
97
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma
Condition(s):Metastatic Melanoma; Skin CancerLast Updated:May 19, 2016Terminated
98
A Study of Adult Participants With BRAF V600 Mutation-Positive Advanced Melanoma Treated With Cobimetinib (Cotellic®) During the French Early Access Program (Temporary Authorization for Use [TAU])
Condition(s):MelanomaLast Updated:January 18, 2019Completed
99
Therapeutic Drug Monitoring of BRAF-mutated Advanced Melanoma
Condition(s):Melanoma (Skin)Last Updated:August 7, 2018Recruiting
100
Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma
Condition(s):Metastatic MelanomaLast Updated:May 1, 2018Completed